MedPath

Double-layer Versus Purse Uterine Closure Techniques : Impact on Residual Myometrial Thickness After Cesarean

Not Applicable
Completed
Conditions
Uterine Scar Defect
Registration Number
NCT04871022
Lead Sponsor
University Tunis El Manar
Brief Summary

There are different surgical techniques of uterine closure during cesarean. Currently data suggest that the double layer unlocked closure technique is associated with better uterine scar healing, and this technique is considered the gold standard.

This study compares two techniques of uterine closure on myometrium thickness:

1. Double layer unlocked suture;

2. Purse suture of the uterus with a first continuous purse suture of the deep portion of the myometrium and a second unlocked continuous suture including the remaining part of the myometrium.

The primary outcome is the mean residual myometrium thickness at the site of the uterine scar evaluated by transvaginal ultrasound at six months after cesarean.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
126
Inclusion Criteria
  • Planned cesarean
  • Primary cesarean
  • ≥ 38 gestational weeks
Exclusion Criteria
  • Previous cesarean
  • Women < 18 years old
  • Multiple gestation
  • Mullerian anomalies
  • Active labor
  • Diabetes
  • BMI >35 kg/m2
  • Placenta praevia
  • Chronic systemic disease
  • Covid-19 infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Residual myometrium thickness6 months after intervention
Secondary Outcome Measures
NameTimeMethod
Operative timeSame day of intervention: day 1
Estimated blood lossSame day of intervention: day 1
Mean number of haemostatic suturesSame day of intervention: day 1
scar widthSame day of intervention: day 1

Trial Locations

Locations (1)

University hospital Mongi Slim la Marsa

🇹🇳

Tunis, La Marsa, Tunisia

University hospital Mongi Slim la Marsa
🇹🇳Tunis, La Marsa, Tunisia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.